Skip to Content
Merck
  • Treatability study of 3,3',4',5-tetrachlorosalicylanilide (TCS) combined with 2,4,6-trichlorophenol (TCP) to reduce excess sludge production in a sequence batch reactor.

Treatability study of 3,3',4',5-tetrachlorosalicylanilide (TCS) combined with 2,4,6-trichlorophenol (TCP) to reduce excess sludge production in a sequence batch reactor.

Bioresource technology (2013-07-17)
Xiao-Chi Feng, Wan-Qian Guo, Chuan Chen, Shan-Shan Yang, Wen-Biao Jin, Nan-Qi Ren, He-Shan Zheng, Juan-Shan Du, Bo Liu
ABSTRACT

The present study investigated the synergistic effects of a novel combined uncoupler of TCS and TCP on excess activated sludge reduction during a 60-day operation using a sequence batch reactor (SBR). Response surface methodology (RSM) was employed to obtain the optimal dosage of the combined uncoupler. The results of 60-day operation demonstrated the combined uncoupler had effectively reduced the sludge yield by approximately 52%, without serious affecting the substrate removal efficiency. The high sludge reduction rate revealed that it was feasible and effective to utilize a combined uncoupler to limit excess activated sludge. The three-dimensional excitation-emission matrix (EEM) fluorescence spectroscopy analysis of activated sludge with different metabolic uncouplers indicated that tryptophan, tyrosine protein-like substances and tryptophan, tyrosine amino-like substances were reduced by adding a combined uncoupler. Moreover, the variation of sludge components provided a better understanding of the effects of uncouplers on activated sludge reduction.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2,4,6-Trichlorophenol, 98%